Manufacturers issue voluntary knee replacement recalls if they discover problems with the devices. In rare cases, the U.S. Food and Drug Administration can order a recall. Manufacturers issued hundreds of knee replacement recalls in recent years. Drugwatch identified 74 knee implant recalls between 2013 and May 2018.
Did you or a loved one suffer complications after receiving a knee replacement? You may be eligible for compensation.
The U.S. Food and Drug Administration keeps track of knee recalls.
The nonprofit consumer-advocacy organization Consumers Union reviewed knee recalls in 2013. It identified 709 recalls in the FDA database between 2003 and 2013.
Drugwatch identified another 74 recalls since the report’s release and May 2018.
Knee implant manufacturers are responsible for appropriate marketing of their products. They must warn consumers and health care professionals about their devices’ risks.
Manufacturers are also responsible for monitoring their products for problems after FDA approval. But critics argue that the FDA approval process does not do enough to keep unsafe devices off the market.
Manufacturers often rely on the agency’s Premarket Notification process. This is also called the 510(k) process.
It lets knee replacement makers skip more rigorous tests. They only have to show their device is “substantially equivalent” to similar products.
Knee replacement lawsuits blame manufacturers for selling defective devices.
Manufacturers issue knee replacement recalls for several reasons. These can be as simple as faulty packaging on knee replacement parts. Or they can involve defective parts that pose a risk of serious injuries.
Three manufacturers account for the majority of knee replacement recalls since 2003.
DePuy Synthes accounted for almost half of those.
Two other companies combined for only 15 recalls between them.
|Knee Replacement Manufacturer||Knee Recalls|
|Smith & Nephew||14|
DePuy Synthes has issued hundreds of recalls over the years.
One of the most recent was in December 2017 for Sigma knee components. The devices had higher than expected failure rates.
DePuy also recalled almost 14,000 Attune knee surgical tools in 2015.
The FDA’s database shows at least six other DePuy knee replacement recalls since 2013.
Between 2003 and 2013, DePuy issued at least 477 knee replacement-related recalls. That’s more than any other knee implant manufacturer.
|December 2017||7,500||SIGMA HP PFJ Cemented Trochlear Implants||Elevated revision rates|
|January 2016||351||SIGMA HP MBT Non-Keel Punch Knee Instruments||Design flaw that could cause a delay in surgery|
|September 2015||7,488||Specialist 2 Intramedullary (SP2 IM) Rod||Instrument fracturing during surgery and leaving parts of the rods in patients|
|June 2015||13,964||Attune Knee Tibial Articulation Surface Instruments||Could come off during surgery, leaving a part in device in the patient|
|March 2015||28,732||LCS Complete RPS Inserts||Reports of higher revision surgery rates in Australia|
|November 2014||7,944||Attune Intuition Impaction Handle||Reports of fractures potentially leaving parts in the patient|
|November 2014||4,555||Attune Intuition Impactors||Could fracture and pieces could be left in the patient|
|February 2014||129||S-ROM Noiles Rotating Hinges||Defective packaging could compromise sterility|
Zimmer Biomet has issued at least 355 knee replacement-related recalls since 2003.
One of the most recent was in 2017 for more than 28,000 joint components. Inspections found elevated endotoxin levels on the parts.
Zimmer Biomet is the largest knee-implant maker in the world. The company took on its present form with the merger of Zimmer and Biomet in 2015.
|November 2017||13,227||Gender Solutions Patello-Femoral Joint System||Packaging problems|
|November 2017||1023||Persona Partial Knee instruments||Spacer blocks do not fit in the alignment tower instrument or handle|
|October 2017||430||Persona Partial Knee Spacer Blocks||Problems with flexion in range-of-motion trials|
|February 2017||28,000||Zimmer Biomet polyethylene joint components||Elevated endotoxin levels|
|January 2017||15,000||Vanguard Total Knee System||Mislabeling and packaging problems|
|May 2016||10,256||Persona Trabecular Metal Tibial Plate Knee implants||Implant loosening|
|January 2016||42,064||Zimmer NexGen Knee implants||Packaging could adhere to implant parts|
Stryker issued 125 knee replacement-related recalls since 2003.
In 2016, the company issued two recalls affecting 14,000 surgical instruments.
|August 2016||2,039||Stryker Orthopaedics Patella Assembly Instruments||Parts could come apart from an accompanying instrument during surgery|
|June 2016||12,469||Modular Handle Triathlon Instruments||Parts could come apart from the rest of the instrument|
|September 2015||3,444||MIS Modular Distal Capture Triathlon Instruments||Reports that parts could come apart from the instruments|
|August 2014||1,147||Triathlon Femoral Components||Packaging issue could affect the shelf life of the devices’ sterility|
|August 2014||1,147||Scorpio Femoral Components||Packaging issue could affect the shelf life of the devices’ sterility|
Smith and Nephew announced 14 knee replacement-related recalls since 2003.
At least three happened since the 2013 Consumer Union analysis.
The most recent recalls affected fewer than 100 total units.
|May 2017||46||Legion Tib Cone Impactor Heads||The wrong adhesive used in assembly|
|March 2016||24||TC-Plus Primary Tibial Components||Manufacturing defect; it could make the polyethylene insert difficult or impossible to seat during surgery|
|January 2016||8||Legion Hemi Stepped Tibial Screw-On Wedges||Screws were too long|
Wright Medical announced four knee replacement recalls since 2003. Drugwatch found none after 2013.
Wright sold its hip and knee division to Corin Orthopaedics in 2016 for a reported $290 million.
Wright is no longer a major player in the knee-implant business.
Please seek the advice of a medical professional before making health care decisions.
Calling this number connects you with Wilson and Peterson, LLP or one of its trusted legal partners. A law firm representative will review your case for free.
Wilson and Peterson, LLP funds Drugwatch because it supports the organization’s mission to keep people safe from dangerous drugs and medical devices.(855) 595-3160